Search results
Results From The WOW.Com Content Network
Anticancer Research was established in 1981 by John G. Delinassios. According to the Journal Citation Reports, the journal had a 2020 impact factor of 2.480 and 25,656 total cites. The 2020 rejection rate was 68%. According to Scimago, the journal belongs to the second quartile (Q2) in the "Medicine" category.
A study published in 2021 compared the Impact Factor, Eigenfactor Score, SCImago Journal & Country Rank and the Source Normalized Impact per Paper, in journals related to Pharmacy, Toxicology and Biochemistry. It discovered there was "a moderate to high and significant correlation" between them. [25]
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
The SJR indicator has been developed to be used in extremely large and heterogeneous journal citation networks. It is a size-independent indicator and its values order journals by their "average prestige per article" and can be used for journal comparisons in science evaluation processes.
The journal covers developments in "medicinal chemistry and rational drug design for the discovery of anti-cancer agents" and publishes original research reports and review papers. [1] It is related to the journal Current Medicinal Chemistry and was established in 2001 as Current Medicinal Chemistry – Anti-Cancer Agents. [2]
The impact factor (IF) or journal impact factor (JIF) of an academic journal is a scientometric index calculated by Clarivate that reflects the yearly mean number of citations of articles published in the last two years in a given journal, as indexed by Clarivate's Web of Science.
A new study in the journal Frontiers in Toxicology found that microplastics in the fish we consume are far more widespread than you may think.. In late December, researchers from Portland State ...
Anti-Cancer Drugs is an international medical journal, which aims to promote and encourage research on anti-cancer agents.It was first published in 1990 and it includes reports on clinical and experimental research results, from conventional cytotoxic chemotherapy to hormonal or biological response modalities. [1]